VMD
Viemed Healthcare Inc
NASDAQ: VMD · HEALTHCARE · MEDICAL DEVICES
$9.49
+0.84% today
Updated 2026-06-03
Market cap
$382.22M
P/E ratio
26.95
P/S ratio
1.33x
EPS (TTM)
$0.37
Dividend yield
—
52W range
$6 – $10
Volume
0.3M
WallStSmart proprietary scores
48
out of 100
Grade: C
Sell
Investment rating
7.3
Growth
B+7.0
Quality
B+6.0
Profitability
B6.3
Valuation
B2/9
Piotroski F-Score
Weak
3.5
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$11.00
+15.91%
12-Month target
$11.56
+21.81%
Intrinsic (DCF)
$11.20
Margin of safety
+24.55%
0 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Altman Z 3.53 — safe zone
+ Free cash flow $1.36M — positive
+ Revenue growth 27.50% QoQ
+ 24.55% below intrinsic value
+ Debt/equity 0.09x — low leverage
Risks
- Piotroski 2/9 — weak financial health
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $138.83M | $183.01M | $224.26M | $270.28M | $286.56M |
| Net income | $6.22M | $10.24M | $11.27M | $14.93M | $2.58M |
| EPS | — | — | — | — | $0.37 |
| Free cash flow | $4.85M | $19.12M | $1.32M | $11.93M | $1.36M |
| Profit margin | 4.48% | 5.60% | 5.02% | 5.53% | 5.20% |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-03-20 | MOORE, MICHAEL | Sale | 65,000 | $8.77 |
| 2026-03-19 | MOORE, MICHAEL | Sale | 40,232 | $9.21 |
| 2026-03-18 | MOORE, MICHAEL | Sale | 31,570 | $9.42 |
Peer comparison
Smart narrative
Viemed Healthcare Inc trades at $9.49. representing a P/E of 26.95x trailing earnings. Our Smart Value Score of 48/100 indicates the stock is fair. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of 3.53, it sits in the safe zone. TTM revenue stands at $286.56M. with profit margins at 5.20%. Our DCF model estimates intrinsic value at $11.20.
Frequently asked questions
What is Viemed Healthcare Inc's stock price?
Viemed Healthcare Inc (VMD) trades at $9.49, on a P/E of 27.0x and a P/S of 1.3x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Viemed Healthcare Inc overvalued?
Viemed Healthcare Inc carries a Smart Value Score of 48/100 (Grade C), which we rate Sell. That score blends growth, quality, and valuation into one read. Our DCF puts intrinsic value at $11.20 versus the $9.49 price, a 24.6% margin of safety on a cash flow basis.
What is the price target of Viemed Healthcare Inc (VMD)?
The 12-month analyst consensus target is $11.00, about 15.9% above the current $9.49. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the intrinsic value of Viemed Healthcare Inc (VMD)?
Our DCF model estimates intrinsic value at $11.20, a +24.6% margin of safety versus today's $9.49. Intrinsic value is what the projected cash flows are worth today. A positive reading means the price sits below that estimate, leaving a cushion if growth holds.
What is Viemed Healthcare Inc's revenue?
Viemed Healthcare Inc's trailing twelve-month revenue is $286.56M. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Viemed Healthcare Inc's Altman Z-Score is 3.53, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio1.33x
ROE10.90%
Beta1.13
50D MA$9.55
200D MA$7.91
Shares out0.04B
Float0.03B
Short ratio—
Avg volume0.3M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—